Respiratory Disease Testing Market Analysis- Size, Share, Trends and Forecasts, 2015 To 2022: Grand View Research

Global respiratory disease testing market is anticipated to register remarkable growth over the coming seven years owing to rising incidence of COPD (chronic obtrusive pulmonary diseases) and other respiratory diseases. In addition, rising geriatric population base and technological advancements in disease testing devices is further expected to fuel the market growth over the forecast period. In 2012, according to a report published by American Lung Associations, COPD was the prime cause of death in the U.S. and is expected to be to the leading respiratory disorder in the coming years.

View Full Report with TOC @

The global respiratory disease testing market is categorized on the basis of tests and end use. The tests segment is sub segmented into imaging tests, peak flow tests, lung volume tests, spirometry tests, blood gas tests and other tests. Imaging tests segment is anticipated to gain substantial market share owing to increasing adoption of imaging measures, especially X-ray. However, the spirometry test segment is expected to witness fastest growth over the coming seven years due to effective and accurate diagnostic results in comparatively shorter time period. By end use, the global respiratory disease testing market is divided into physician offices, hospitals and clinical laboratories. Hospitals are anticipated to witness highest growth as majority of the respiratory diagnostic instruments such as spirometers and X-ray machines are widely used in hospitals. Regionally, as of 2014, North America held the largest market share due to rising prevalence of respiratory diseases, demand for health care devices and increased usage of portable devices. European region is also expected to witness substantial market growth due to growing geriatric population base and healthcare awareness. Rise in personal disposable income, untapped opportunities and increasing number of hospitals in India and China is expected to provide lucrative growth platform to respiratory disease testing market in Asia pacific region. Similarly, rising incidence rate of respiratory diseases, improving healthcare facilities and growing investments are expected to fuel the growth of the respiratory disease testing market in Latin America.

The key companies operating in respiratory disease testing market are Carestream Health Inc., GE Healthcare, Futuremed America Inc., COSMED, MGC Diagnostic Corporation, Philips Healthcare, Perkin Elmer Inc., Carefusion Corporation, ndd Medical Technologies Inc., SDI Diagnostics, Smiths Medical, Nihon Kohden Corporation and Siemens Healthcare.The companies are adopting competitive market strategies such as research alliance and new product development to increase their market penetration. For example, in April 2015, Carefusion Corporation launched a product namely MicroRPM capable of measuring expiratory and inspiratory mouth pressures and (SNIP) sniff nasal pressures simultaneously.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For More Information, Visit Grand View Research


Sherry James

Corporate Sales Specialist, U.S.A.

Grand View Research, Inc.

United States

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519


Blog Site: